Jonathan Hale Zippin
Director/Board Member presso FOXWAYNE ENTERPRISES ACQUISITION CORP.
Profilo
Jonathan Hale Zippin is the founder of CEP Biotech, Inc. He is currently an Independent Director at FoxWayne Enterprises Acquisition Corp.
and an Associate Professor at Weill Cornell Medical College.
He is also a Member of the Society for Investigative Dermatology and the American Contact Dermatitis Society.
Posizioni attive di Jonathan Hale Zippin
Società | Posizione | Inizio |
---|---|---|
FOXWAYNE ENTERPRISES ACQUISITION CORP. | Director/Board Member | - |
Weill Cornell Medical College | Corporate Officer/Principal | 01/01/2010 |
Society for Investigative Dermatology | Corporate Officer/Principal | - |
American Contact Dermatitis Society
American Contact Dermatitis Society Medical/Nursing ServicesHealth Services The American Contact Dermatitis Society promotes, supports, develops, and stimulates information about contact dermatitis and occupational skin disease. The private company is based in Bunnell, FL. | Corporate Officer/Principal | - |
Precedenti posizioni note di Jonathan Hale Zippin
Società | Posizione | Fine |
---|---|---|
CEP Biotech, Inc. | Founder | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 4 |
---|---|
Society for Investigative Dermatology | |
American Contact Dermatitis Society
American Contact Dermatitis Society Medical/Nursing ServicesHealth Services The American Contact Dermatitis Society promotes, supports, develops, and stimulates information about contact dermatitis and occupational skin disease. The private company is based in Bunnell, FL. | Health Services |
CEP Biotech, Inc. | |
FoxWayne Enterprises Acquisition Corp.
FoxWayne Enterprises Acquisition Corp. Financial ConglomeratesFinance FoxWayne Enterprises Acquisition Corp. operates as a blank check company. It seeks to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination. It focuses its search for business in the biotechnology and telemedicine sector of the healthcare industry. The company was founded by Robbie Knie on September 17, 2020 and is headquartered in New York, NY. | Finance |
- Borsa valori
- Insiders
- Jonathan Hale Zippin